Blood Screening Market Is Forecast to Exceed CAGR of 9.68% during 2014-2023

Industry Outlook and Trend Analysis:
The Blood Screening Market was worth USD 1.35 billion in 2014 and is expected to reach approximately USD 3.10 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.68% during the forecast period.

Blood Screening is the key part to prevent degenerative infection. By giving a far reaching preview of your present condition of wellbeing, blood screening can detect potential medical issues. Increasing numbers of blood donors and blood donations coupled with rising awareness about safety of donated blood are the key factors that are propelling the growth of Blood Screening Market.

Browse Full Report @ .

Key Growing Factors:
The key aspects that fuel the development of the worldwide blood screening market incorporate increment in pervasiveness of irresistible infections, ascend in number of blood gifts, increment in mindfulness about social insurance, and surge in appropriation of nucleic acid amplification test (NAT). Besides, ascend in social insurance activities by government, increment in medicinal services use, and mechanical progressions in blood screening advancements have energized the market development.

Competitive Insights:
The leading players in the market are Bio-Rad Laboratories Inc., Abbott Laboratories, Becton, Dickinson and Company, Beckman Coulter Inc., Ortho Clinical Diagnostics Inc., Thermo Fisher Scientific Inc., bioMérieux, Siemens Healthineers, Roche Diagnostics, and Grifols.

Table of Contents:
2.Executive Summary
3.Market Overview
4.Market Analysis by Regions

4.1.North America (United States, Canada and Mexico)
4.1.1.United States Market States and Outlook (2014-2023)
4.1.2.Canada Market States and Outlook (2014-2023)
4.1.3.Mexico Market States and Outlook (2014-2023)
4.2.Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1.Germany Market States and Outlook (2014-2023)
4.2.2.France Market States and Outlook (2014-2023)
4.2.3.UK Market States and Outlook (2014-2023)
4.2.4.Russia Market States and Outlook (2014-2023)
4.2.5.Italy Market States and Outlook (2014-2023)
4.2.6.Rest of Europe Market States and Outlook (2014-2023)
4.3.Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1.China Market States and Outlook (2014-2023)
4.3.2.Japan Market States and Outlook (2014-2023)
4.3.3.Korea Market States and Outlook (2014-2023)
4.3.4.India Market States and Outlook (2014-2023)
4.3.5.Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4.South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1.Brazil Market States and Outlook (2014-2023)
4.4.2.Argentina Market States and Outlook (2014-2023)
4.4.3.Columbia Market States and Outlook (2014-2023)
4.4.4.Rest of South America Market States and Outlook (2014-2023)
4.5.Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1.Saudi Arabia Market States and Outlook (2014-2023)
4.5.2.UAE Market States and Outlook (2014-2023)
4.5.3.Egypt Market States and Outlook (2014-2023)
4.5.4.Nigeria Market States and Outlook (2014-2023)
4.5.5.South Africa Market States and Outlook (2014-2023)
4.5.6.Rest of MEA Market States and Outlook (2014-2023)
To be Continued…

Get Sample Copy of This Report @ .

Technology Outlook and Trend Analysis:
According to the Type the market of Blood Screening is divided into NGS, Nucleic Acid Amplification (NAT), ELISA, (CLIA, Fluorescence assay), (rPCR), Western Blotting, Rapid Test. Due to its increasing affordability, accuracy, and other factors such as rise in number of blood donors. NAT is one of the major players in the market. It is further segmented into Transcription-Mediated Amplification (TMA) and Real-Time PCR. Also the ELISA test is further divided into Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassays (FIA), and Colorimetric Immunoassay (CI).

Product Outlook and Trend Analysis:
Reagents & Kits, Instruments, and Software & Services are various categories into which the product segment is divided into. The Reagents & Kits segment is further categorised as ELISA Reagents & Kits, NAT Reagent & Kits, and Others. The Reagent & Kits segment is predicted to dominate throughout the forecast period owing to increasing demand.

End User Outlook and Trend Analysis:
The End User segment is fragmented into Hospitals and Blood Bank. The Blood bank sector is expected to rule the market whilst holding the largest share due to increasing incidents of blood donations, increasing no. of donors and huge number of organ replacements and organ donations taking place across the world.

Regional Outlook and Trend Analysis:
According to the region, the Blood Screening Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The North-America Region is expected to rule the market in terms of volume as well as value which is followed by Europe. The Asia-Pacific Market is expected to grow at highest CAGR during the forecast period owing to increasing demand for blood screening in the countries like India, China and Japan.

Make an Inquiry @ .

About Crystal Market Research:
Crystal Market Research
is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282